Second-trimester fetal growth as a predictor of poor obstetric and neonatal outcome in patients with low first-trimester serum pregnancy-associated plasma protein-A and a euploid fetus

Ultrasound in Obstetrics and Gynecology

Volumn 33, Issue 1, 2009, Pages 34-38

  Fox, N S ^a,b   Shalom, D ^a   Chasen, S T ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Maternal Fetal Medicine Associates   (United States)

Author keywords

Fetal growth restriction; Pregnancy associated plasma protein A; Second trimester; Ultrasound

Indexed keywords

PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; APGAR SCORE; ARTICLE; CONTROLLED STUDY; FEMALE; FETUS; FETUS DEATH; FETUS ECHOGRAPHY; FETUS GROWTH; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HOSPITAL ADMISSION; HUMAN; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MATERNAL SERUM; NEWBORN ASSESSMENT; NEWBORN DEATH; NEWBORN INTENSIVE CARE; OUTCOME ASSESSMENT; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SECOND TRIMESTER PREGNANCY; SMALL FOR DATE INFANT;

ANEUPLOIDY; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; FETAL GROWTH RETARDATION; HUMANS; INFANT, NEWBORN; MATERNAL AGE; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; ULTRASONOGRAPHY, PRENATAL;

EID: 58149520507     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.6274     Document Type: Article

References (21)

1. American College of Obstetricians and Gynecologists. Screening for Chromosomal Abnormalities. ACOG Practice Bulletin 77. ACOG: Washington, DC, 2007.
2. Bindra R, Heath V, Liao A, Spencer K, Nicolaides KH. One stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15030 pregnancies. Ultrasound Obstet Gynecol 2002; 20: 219-225.
3. Wapner R, Thom E, Simpson JL, Pergament E, Silver R, Filkins K, Platt L, Mahoney M, Johnson A, Hogge WA, Wilson RD, Mohide P, Hershey D, Krantz D, Zachary J, Snijders R, Greene N, Sabbagha R, MacGregor S, Hill L, Gagnon A, Hallahan T, Jackson L. First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. First-trimester screening for trisomies 21 and 18. N Engl J Med 2003; 349: 1405-1413.
4. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Dukes K, Bianchi DW, Rudnicka AR, Hackshaw AK, Lambert-Messerlian G, Wald NJ, D'Alton ME. First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005; 353: 2001-2011.
5. Perni SC, Predanic M, Kalish RB, Chervenak FA, Chasen ST. Clinical use of first-trimester aneuploidy screening in a United States population can replicate data from clinical trials. Am J Obstet Gynecol 2006; 194: 127-130.
6. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Munson ML. Births: Final Data for 2003. National Vital Statistics Reports; vol 54 no 2. National Center for Health Statistics: Hyattsville, MD, 2005.
7. Hadlock FP, Harrist RB, Sharman RS, Deter RL, Park SK. Estimation of fetal weight with the use of head, body, and femur measurements - a prospective study. Am J Obstet Gynecol 1985; 151: 333-337.
8. Shepard MJ, Richards VA, Berkowitz RL, Warsof SL, Hobbins JC. An evaluation of two equations for predicting fetal weight by ultrasound. Am J Obstet Gynecol 1982; 142: 47-54.
9. Hadlock FP, Harrist RB, Martinez JP. In utero analysis of fetal growth: a sonographic weight standard. Radiology 1991; 181: 129-133.
10. Krantz D, Goetzl L, Simpson JL, Thom E, Zachary J, Hallahan TW, Silver R, Pergament E, Platt LD, Filkins K, Johnson A, Mahoney M, Hogge WA, Wilson RD, Mohide P, Hershey D, Wapner R; First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol 2004; 191: 1452-1458.
11. Smith GC, Shah I, Crossley JA, Aitken DA, Pell JP, Nelson SM, Cameron AD, Connor MJ, Dobbie R. Pregnancy-associated plasma protein A and alpha-fetoprotein and prediction of adverse perinatal outcome. Obstet Gynecol 2006; 107: 161-166.
12. Fox NS, Huang M, Chasen ST. Second trimester fetal growth and the risk of poor obstetric and neonatal outcomes. Ultrasound Obstet Gynecol 2008; 32: 61-65.
13. Rasmussen S, Kiserud T, Albrechtsen S. Foetal size and body proportion at 17-19 weeks of gestation and neonatal size, proportion, and outcome. Early Hum Dev 2006; 82: 683-690.
14. Nakling J, Backe B. Adverse obstetric outcome in fetuses that are smaller than expected at second trimester routine ultrasound examination. Acta Obstet Gynecol Scand 2002; 81: 846-851.
15. Kalish RB, Thaler HT, Chasen ST, Gupta M, Berman SJ, Rosenwaks Z. First- and second-trimester ultrasound assessment of gestational age. Am J Obstet Gynecol 2004; 191: 975-978.
16. Shipp TD, Bromley B, Pauker S, Frigoletto FD, Benacerraf BR. Outcome of singleton pregnancies with severe oligohydramnios in the second and third trimesters. Ultrasound Obstet Gynecol 1996; 7: 108-113.
17. Al-Kouatly HB, Chasen ST, Karam AK, Ahner R, Chervenak FA. Factors associated with fetal demise in fetal echogenic bowel. Am J Obstet Gynecol 2001; 185: 1039-1043.
18. American College of Obstetricians and Gynecologists. Diagnosis and Management of Preeclampsia. ACOG Practice Bulletin 33. ACOG: Washington, DC, 2002.
19. Oken E, Kleinman KP, Rich-Edwards J, Gillman MW. A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr 2003; 3: 6.
20. Harrington K, Carpenter RG, Goldfrad C, Campbell S. Transvaginal Doppler ultrasound of the uteroplacental circulation in the early prediction of pre-eclampsia and intrauterine growth retardation. Br J Obstet Gynaecol 1997; 104: 674-681.
21. Hafner E, Metzenbauer M, Hofinger D, Stonek F, Schuchter K, Waldhor T, Philipp K. Comparison between three-dimensional placental volume at 12 weeks and uterine artery impedance/ notching at 22 weeks in screening for pregnancy-induced hypertension, pre-eclampsia and fetal growth restriction in a low-risk population. Ultrasound Obstet Gynecol 2006; 27: 652-657.